tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Nierengarten, 328 are a BUY (82.41%), 68 are a HOLD (17.09%), 2 are a SELL (0.5%).
Analyst David Nierengarten, currently employed at WEDBUSH, carries an average stock price target met ratio of 45.36% that have a potential upside of 45.61% achieved within 207 days.
David Nierengarten’s has documented 878 price targets and ratings displayed on 66 stocks. The coverage is on Healthcare, Communication Services, Technology sectors.
Most recent stock forecast was given on BEAM, Beam Therapeutics at 25-Feb-2026.
Analyst best performing recommendations are on SRRK (SCHOLAR ROCK HOLDING CORP).
The best stock recommendation documented was for SRRK (SCHOLAR ROCK HOLDING CORP) at 6/18/2018. The price target of $25 was fulfilled within 1 day with a profit of $3.57 (16.66%) receiving and performance score of 166.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Oct-2025
$78
$22.95 (41.69%)
$55
1 months 8 days ago
(20-Jan-2026)
1/4 (25%)
$31.79 (68.79%)
56
Buy Since 21-Feb-2024
$56
$0.95 (1.73%)
$80
2 months 17 days ago
(11-Dec-2025)
3/4 (75%)
$10.22 (22.32%)
365
Buy Since 04-Jun-2025
$51
$-4.05 (-7.36%)
$52
3 months 4 days ago
(24-Nov-2025)
11/12 (91.67%)
$9.05 (21.57%)
277
Buy Since 01-Nov-2022
$100
$44.95 (81.65%)
$90
3 months 23 days ago
(05-Nov-2025)
6/12 (50%)
$64 (177.78%)
461
Buy Since 10-May-2024
$70
$14.95 (27.16%)
$40
4 months 13 days ago
(15-Oct-2025)
13/19 (68.42%)
$35.71 (104.14%)
147
Which stock is David Nierengarten is most bullish on?
Which stock is David Nierengarten is most reserved on?
What Year was the first public recommendation made by David Nierengarten?
